Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.043 USD | +167.08% | +167.08% | +95.45% |
2023 | THC Farmaceuticals, Inc. announced that it expects to receive $0.124 million in funding | CI |
2021 | Thc Farmaceuticals, Inc. Announces Final Departure of Mike Gravel, Chairman | CI |
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Novel Cannabinoid-based Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -70.51% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -70.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Grossman
CEO | Chief Executive Officer | - | - |
Gary Henrie
LAW | General Counsel | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Tobias
BRD | Director/Board Member | 73 | - |
Mark Grossman
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,131,600 | 3,738,000 ( 20.62 %) | 1,500,000 ( 8.273 %) | 20.62 % |
Company contact information
THC Farmaceuticals, Inc.
1000 Newbury Road Suite 138-B
91320, Thousand Oaks
+480-725-9060
http://www.cbdg.comSector
1st Jan change | Capi. | |
---|---|---|
+95.45% | 780K | |
+13.25% | 2.91B | |
+14.12% | 1.69B | |
+84.57% | 625M | |
+3.64% | 485M | |
+29.11% | 159M | |
+13.51% | 108M | |
+52.81% | 56.96M |
- Stock Market
- Equities
- CBDG Stock
- Company THC Farmaceuticals, Inc.